| Financial Year |
March 31 2022 |
| Monetary Funds |
1,335,628,749.41 |
| Held-for-trading Financial Assets |
4,893.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,745,054.60 |
| Advances to Suppliers |
9,985,438.02 |
| Other Receivables |
39,896,302.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
461,504,014.75 |
| Total Current Assets |
2,039,555,586.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
800,573,785.47 |
| Investment Properties |
4,065,440,925.13 |
| Fixed Assetes |
168,482,739.72 |
| Under-construction Projects |
91,170,053.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,678,242.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,954,096.77 |
| Deferred Income Tax Assets |
18,762,567.94 |
| Other Non-Current Assets |
6,570,998.18 |
| Sub-Total of Non-Current Assets |
6,982,097,137.09 |
| Total Assets |
9,021,652,723.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,714,786.70 |
| Accounts Received In Advance |
2,547,530,239.79 |
| Employee Compensation Payable |
8,137,726.09 |
| Taxes Payable |
35,350,395.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
245,059,523.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
157,023.58 |
| Sub-Total of Current Liabilities |
2,876,819,558.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
195,137,467.51 |
| Other Non-Current Liabilities |
490,000.00 |
| Sub-Total of Non-Current Liabilities |
210,141,949.53 |
| Total Liabilities |
3,086,961,507.69 |
| Paid-In Capital(Or Share Stock) |
1,465,790,928.00 |
| Capital Surplus |
1,152,909,953.28 |
| Surplus Reserve |
435,518,076.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,182,093,009.60 |
| Minority Stockholder's Interest |
112,966,846.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,821,724,369.49 |
| Owner's Equity（Stockholder's Equity） |
5,934,691,215.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,021,652,723.55 |
